PUBLISHER: The Business Research Company | PRODUCT CODE: 1942512
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942512
Capnography devices are medical instruments designed to measure and monitor the levels of carbon dioxide (CO2) in a patient's exhaled breath. They offer real-time insights into respiratory status, aid in identifying respiratory conditions, ensure adequate ventilation, and assist in managing anesthesia during surgeries.
The primary component types of capnography devices are original equipment manufacturer (OEM) modules and other components. OEM modules are produced by one company and incorporated into final products made by another company. These devices come in hand-held, stand-alone, and multi-parameter forms and utilize technologies such as mainstream, sidestream, and microstream. Capnography devices are applied in areas including emergency medicine, pain management, procedural sedation, and critical care, among others. They are used by a range of end-users, including hospitals, ambulatory care centers, and other facilities.
Tariffs are impacting the capnography devices market by increasing costs for imported electronic components, sensors, and OEM modules used in hand-held and multi-parameter systems. These cost increases have affected device pricing and procurement, particularly across hospitals and ambulatory care settings in regions such as asia-pacific and europe where cross-border manufacturing is common. Higher tariffs have slightly slowed replacement cycles and new installations. However, tariffs have also encouraged local assembly, regional sourcing, and greater manufacturing self-reliance, supporting long-term supply chain stability.
The capnography devices market research report is one of a series of new reports from The Business Research Company that provides capnography devices market statistics, including capnography devices industry global market size, regional shares, competitors with a capnography devices market share, detailed capnography devices market segments, market trends and opportunities, and any further data you may need to thrive in the capnography devices industry. This capnography devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The capnography devices market size has grown rapidly in recent years. It will grow from $0.83 billion in 2025 to $0.92 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to growth in surgical procedures, increasing use of anesthesia in clinical care, rising adoption of respiratory monitoring in hospitals, expansion of emergency medical services, increasing awareness of patient safety during ventilation.
The capnography devices market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to rising prevalence of respiratory disorders, growing demand for continuous ventilation monitoring, expansion of ambulatory and outpatient procedures, increasing focus on early detection of respiratory compromise, rising adoption of capnography in non-hospital settings. Major trends in the forecast period include increasing adoption of capnography in emergency and critical care, rising use of capnography for procedural sedation monitoring, growing demand for portable and hand-held capnography devices, expansion of capnography use beyond operating rooms, increasing integration of capnography in multi-parameter monitors.
The increasing prevalence of respiratory diseases is expected to drive the growth of the capnography devices market in the coming years. Respiratory diseases encompass a range of conditions that impact the lungs and respiratory system, such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and lung cancer, which hinder breathing and can lead to severe health issues. The rising incidence of respiratory diseases is attributed to factors such as worsening air pollution, higher smoking rates, and aging populations. Capnography devices play a crucial role in monitoring and assessing patients' ventilation status, enabling the detection of abnormalities in real time. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian health agency, reported that approximately 8.5 million Australians, or 34% of the population, were living with chronic respiratory conditions. This includes an estimated 2.8 million individuals (11% of the population) with asthma and 638,000 people (2.5% of the population) suffering from COPD. As a result, the growing prevalence of respiratory diseases is fueling the demand for capnography devices.
Major companies in the capnography devices market are intensifying their efforts to develop advanced pilot studies to secure a competitive advantage. Pilot studies are preliminary research efforts designed to assess the feasibility, effectiveness, and potential impact of these devices in clinical environments. For example, in March 2024, TidalSense, a UK-based company specializing in respiratory devices, launched a pilot study to evaluate its innovative N-Tidal device for diagnosing asthma in young children. This study, conducted in collaboration with the University of Nottingham and Nottingham University Hospitals NHS Trust, will include 75 children under five who are experiencing asthma and viral wheezing. The N-Tidal device employs capnography technology to measure carbon dioxide levels during normal breathing, thus bypassing the need for complex spirometry tests that are often challenging for young children, potentially leading to inaccurate diagnoses and extended hospital stays.
In June 2023, Masimo, a U.S.-based medical technology company focused on noninvasive monitoring solutions, broadened its long-standing collaboration with Royal Philips to incorporate Masimo's CO2 (capnography) measurements, along with SedLine brain function monitoring and O3 regional oximetry, into Philips' IntelliVue MX750 and MX850 high-acuity patient monitors. Through this expanded partnership, the companies aim to strengthen advanced patient-monitoring capabilities in operating rooms and intensive care units by combining Philips' patient-monitoring platforms with Masimo's capnography and multimodal monitoring technologies, enabling more accurate clinical decision-making and enhanced patient safety in critical-care settings. Royal Philips is a Netherlands-based health technology company.
Major companies operating in the capnography devices market are Medtronic PLC, GE HealthCare Technologies Inc., Koninklijke Philips NV, Masimo Corporation, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, Mindray Medical International Limited, ZOLL Medical Corporation, Spacelabs Healthcare Inc., Vyaire Medical Inc., Edan Instruments Inc., Criticare Systems Inc., Opto Circuits India Limited, Infinium Medical Inc., Weinmann Emergency Medical Technology GmbH & Co. KG, BPL Medical Technologies Pvt Ltd., Smiths Group PLC, Nonin Medical Inc., Shenzhen Creative Industry Co Ltd, Shenzhen Comen Medical Instruments Co Ltd
North America was the largest region in the capnography devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capnography devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the capnography devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The capnography devices market consists of sales of carbon dioxide (CO2) sensors, sampling lines, and display units. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Capnography Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses capnography devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for capnography devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The capnography devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.